New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.

New oral anti-coagulants versus vitamin K antagonists in high thromboembolic risk patients.

<h4>Background</h4>Oral anticoagulant therapy (VKA) is nowadays the mainstay of treatment in primary and secondary stroke prevention in patients with atrial fibrillation. Given the limited risk-benefit ratio of vitamin K antagonists, pharmacological research has been directed towards the...

Full description

Bibliographic Details
Main Authors: Annachiara Bellin, Patrizia Berto, Sakis Themistoclakis, Aastha Chandak, Pietro Giusti, Giacomo Cavalli, Sumeet Bakshi, Michele Tessarin, Paola Deambrosis, Alessandro Chinellato
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0222762

Internet

https://doi.org/10.1371/journal.pone.0222762

Similar Items